Mujie Ye

784 total citations
38 papers, 510 citations indexed

About

Mujie Ye is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Mujie Ye has authored 38 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 18 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Mujie Ye's work include Neuroendocrine Tumor Research Advances (11 papers), RNA modifications and cancer (11 papers) and Neuroblastoma Research and Treatments (10 papers). Mujie Ye is often cited by papers focused on Neuroendocrine Tumor Research Advances (11 papers), RNA modifications and cancer (11 papers) and Neuroblastoma Research and Treatments (10 papers). Mujie Ye collaborates with scholars based in China, South Korea and Germany. Mujie Ye's co-authors include Kuiran Dong, Baihui Liu, Meng Wei, Jinhao Chen, Qiyun Tang, Jian’an Bai, Duan Ma, Jingjing Zhang, Wei Meng and Chunhua Hu and has published in prestigious journals such as Chemical Engineering Journal, The FASEB Journal and Cellular and Molecular Life Sciences.

In The Last Decade

Mujie Ye

33 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mujie Ye China 16 400 257 81 50 39 38 510
Yuanfei Shi China 11 375 0.9× 160 0.6× 97 1.2× 18 0.4× 30 0.8× 26 488
Nils Degrauwe Switzerland 5 342 0.9× 198 0.8× 59 0.7× 20 0.4× 24 0.6× 7 431
Zhonghai Guan China 8 280 0.7× 189 0.7× 78 1.0× 46 0.9× 41 1.1× 18 370
Sheng‐Yan Huang China 11 245 0.6× 123 0.5× 53 0.7× 25 0.5× 58 1.5× 21 339
Qunhui Wang China 11 217 0.5× 148 0.6× 75 0.9× 30 0.6× 152 3.9× 42 390
Yuejie Lu China 9 545 1.4× 428 1.7× 71 0.9× 48 1.0× 104 2.7× 15 678
Yuan Lu China 13 360 0.9× 291 1.1× 59 0.7× 24 0.5× 44 1.1× 26 491
Huafei Shen China 8 297 0.7× 148 0.6× 65 0.8× 15 0.3× 19 0.5× 16 374
Rogelio Medina United States 9 180 0.5× 154 0.6× 64 0.8× 37 0.7× 14 0.4× 15 312
Yifan Zeng China 8 277 0.7× 142 0.6× 73 0.9× 12 0.2× 36 0.9× 17 377

Countries citing papers authored by Mujie Ye

Since Specialization
Citations

This map shows the geographic impact of Mujie Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mujie Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mujie Ye more than expected).

Fields of papers citing papers by Mujie Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mujie Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mujie Ye. The network helps show where Mujie Ye may publish in the future.

Co-authorship network of co-authors of Mujie Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Mujie Ye. A scholar is included among the top collaborators of Mujie Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mujie Ye. Mujie Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ye, Mujie, Jian’an Bai, Hongbo Wang, et al.. (2025). Dual targeting of PI3K and mTOR induce necroptosis to enhance therapeutic efficacy in pancreatic neuroendocrine tumors. Chemical Engineering Journal. 521. 166489–166489.
2.
Ye, Mujie, Guozhi Zhou, Jinhao Chen, et al.. (2025). Characteristics and function of the gut microbiota in patients with rectal neuroendocrine tumors. Journal of Cancer. 16(4). 1040–1050. 1 indexed citations
3.
4.
Hu, Chunhua, et al.. (2025). Metabolic changes in neuroendocrine neoplasms. Cellular and Molecular Life Sciences. 82(1). 205–205.
5.
Yan, Lijun, Mujie Ye, Jianqiang Qian, et al.. (2025). PROTAC-Surufatinib Suppresses Pancreatic Neuroendocrine Neoplasms Progression by Inducing Ferroptosis through Inhibiting WNT/β-catenin Pathway Mediated by HMOX1. International Journal of Biological Sciences. 21(6). 2476–2492. 1 indexed citations
6.
Zhang, Jingjing, et al.. (2025). Carbonyl reductase 4 suppresses colorectal cancer progression through the DNMT3B/CBR4/FASN/mTOR axis. Cancer Cell International. 25(1). 146–146.
7.
Chen, Jinhao, Mujie Ye, Ping Yu, et al.. (2025). FTO-induced APOE promotes the malignant progression of pancreatic neuroendocrine neoplasms through FASN-mediated lipid metabolism. International Journal of Biological Sciences. 21(4). 1478–1496. 4 indexed citations
8.
9.
10.
Hu, Chunhua, Mujie Ye, Jian’an Bai, et al.. (2024). FOXA2-initiated transcriptional activation of INHBA induced by methylmalonic acid promotes pancreatic neuroendocrine neoplasm progression. Cellular and Molecular Life Sciences. 81(1). 50–50. 4 indexed citations
11.
Zhang, Shijie, et al.. (2024). Identification of EGR4 as a prospective target for inhibiting tumor cell proliferation and a novel biomarker in colorectal cancer. Cancer Gene Therapy. 31(6). 871–883. 3 indexed citations
12.
Ye, Mujie, Jian’an Bai, Jinhao Chen, et al.. (2024). Hypoxia upregulating ACSS2 enhances lipid metabolism reprogramming through HMGCS1 mediated PI3K/AKT/mTOR pathway to promote the progression of pancreatic neuroendocrine neoplasms. Journal of Translational Medicine. 22(1). 93–93. 24 indexed citations
13.
Chen, Jinhao, Mujie Ye, Jian’an Bai, et al.. (2023). Novel insights into the interplay between m6A modification and programmed cell death in cancer. International Journal of Biological Sciences. 19(6). 1748–1763. 16 indexed citations
14.
Ye, Mujie, Jinhao Chen, Yanling Xu, et al.. (2023). Orlistat Induces Ferroptosis in Pancreatic Neuroendocrine Tumors by Inactivating the MAPK Pathway. Journal of Cancer. 14(8). 1458–1469. 5 indexed citations
15.
Chen, Jinhao, Mujie Ye, Jian’an Bai, et al.. (2023). ALKBH5 enhances lipid metabolism reprogramming by increasing stability of FABP5 to promote pancreatic neuroendocrine neoplasms progression in an m6A-IGF2BP2-dependent manner. Journal of Translational Medicine. 21(1). 741–741. 24 indexed citations
16.
Ye, Mujie, Shiyu Chen, Jian’an Bai, et al.. (2023). FAM201A encodes small protein NBASP to inhibit neuroblastoma progression via inactivating MAPK pathway mediated by FABP5. Communications Biology. 6(1). 714–714. 9 indexed citations
17.
Ye, Mujie, Chunhua Hu, Ping Yu, et al.. (2023). FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression. International Journal of Biological Sciences. 19(10). 3115–3127. 33 indexed citations
18.
Chen, Shiyu, Zhonglin Jia, Ming Cai, et al.. (2021). SP1-Mediated Upregulation of Long Noncoding RNA ZFAS1 Involved in Non-syndromic Cleft Lip and Palate via Inactivating WNT/β-Catenin Signaling Pathway. Frontiers in Cell and Developmental Biology. 9. 662780–662780. 9 indexed citations
19.
Ye, Mujie, Jingjing Zhang, Wei Meng, Baihui Liu, & Kuiran Dong. (2020). Emerging role of long noncoding RNA-encoded micropeptides in cancer. Cancer Cell International. 20(1). 506–506. 63 indexed citations
20.
He, Weijing, Jingjing Zhang, Baihui Liu, et al.. (2020). S119N Mutation of the E3 Ubiquitin Ligase SPOP Suppresses SLC7A1 Degradation to Regulate Hepatoblastoma Progression. Molecular Therapy — Oncolytics. 19. 149–162. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuanfei Shi Breakdown of academic impact, for papers by Nils Degrauwe Breakdown of academic impact, for papers by Zhonghai Guan Breakdown of academic impact, for papers by Sheng‐Yan Huang Breakdown of academic impact, for papers by Qunhui Wang Breakdown of academic impact, for papers by Yuejie Lu Breakdown of academic impact, for papers by Yuan Lu Breakdown of academic impact, for papers by Huafei Shen Breakdown of academic impact, for papers by Rogelio Medina Breakdown of academic impact, for papers by Yifan Zeng
Rankless by CCL
2026